Iniston antitusivo descongestivo 200 ml
Symptomatic relief of nonproductive cough (dry cough and nervous cough) and nasal congestion in catarrh, flu or common cold.
Security: Web with SSL certificate to guarantee security in all transactions
Shipping: Express delivery with package tracking number
Returns: We accept returns (See section Terms and conditions)
You might also like
Each 5 ml contains:
Triprolidine hydrochloride 1.25 mg
Pseudoephedrine Hydrochloride 30 mg
Dextromethorphan hydrobromide 10 mg
Sucrose, ethanol (5% v / v), Sorbitol, sodium benzoate, methyl hydroxybenzoate, Cochineal Red A (Ponceau 4R E124), aroma of blackberry, menthol, vanillin and Purified water q.s.
Triprolidine provides symptomatic relief in dependent wholly or partly of the release of histamine allergies.
Pseudoephedrine is a decongestant of the mucous membranes of the upper respiratory tract, especially the nasal mucous membranes.
Dextromethorphan hydrobromide has a specific and pronounced on irritation cough center inhibitory action, so it is effective against various forms of cough. It has no narcotic or analgesic action.
Symptomatic relief of nonproductive cough (dry cough and nervous cough) and nasal congestion and catarrh common cold.
Adults and children over 12 years old: 10 ml, 3 times a day.
Children 6 to 12 years old: 5 ml, 3 times a day.
Geriatric Use: the same dose as for adults, but it would be advisable to monitor renal function and / or liver is recommended. Seek medical advice.
It is recommended to drink water after each dose of medication.
Iniston cough suppressant and DECONGESTANT is contraindicated in individuals with hypersensitivity to any of its components.
Contraindicated in patients with hypertension or severe coronary artery disease or in cases of hyperthyroidism in patients being treated for Parkinson's or MAOI antidepressants (inhibitors monoamiooxidasa) or have received this treatment in the previous two weeks. Women breast feeding should not take this medicine as it passes into breast milk.
should not be administered in patients with chronic and due to persistent cough or snuff,
Asthma or emphysema or where cough is accompanied by excessive secretions or active tuberculosis. It should not be administered to patients with respiratory failure.
Do not administer to children under 6 years old without consulting the doctor. Do not exceed the recommended dose. Should not be used with other products containing nasal decongestants.
Iniston cough suppressant and DECONGESTANT should be administered with caution in patients with diabetes mellitus, heart and kidney disorders, anemia or elevated intraocular pressure (glaucoma).
This product may cause drowsiness and impaired the results of tests of auditory vigilance. Patients should not drive or operate hazardous machinery to determine their level of response.
Patients treated with Iniston cough suppressant and DECONGESTANT should avoid simultaneous use of alcohol intake during the treatment period or the use of medicines that act centrally as they can accentuate the appearance of side effects.
It should be used with caution in case of prostate disorders and liver disease.
Consult your doctor if the cough persists for more than five days, tends to worsen or if accompanied by fever, rash, headache or sore throat.
Iniston DECONGESTANT cough suppressant and should be used with caution in patients with antihypertensive medicines, tricyclic antidepressants or other sympathomimetic medicines.
IMPORTANT FOR WOMEN: If you are pregnant or think you may be pregnant, consult your doctor before taking this medicine. Medicine use during pregnancy can be dangerous for the embryo or fetus and should be monitored by the doctor.
Athletes are informed that this medicine contains a component that can establish an analytical result of doping control as positive.
This medicine contains 2,835 g of sucrose per 5 ml, which should be considered in patients with hereditary fructose intolerance, glucose absorption problems / galactose, sucrose-isomaltase deficiency and diabetic patients.
This product contains 5% v / v ethanol in final volume. Each 5 ml containing 0.201 g of ethanol which can be a risk in children, pregnant women and patients with liver disease, alcoholism, epilepsy, brain damage or injuries. You can modify or enhance the effect of other medicines.
This medicine contains 1 g of sorbitol per 5 ml. It can cause stomach upset and diarrhea. Should not be used in patients with hereditary fructose intolerance.
This medicine contains Cochineal Red A (Ponceau 4R E124) as an excipient. It can cause allergic reactions, including asthma, particularly in patients allergic to acetylsalicylic acid.
Concomitant use of Iniston cough suppressant and decongestant sympathomimetic medicines can occasionally cause a rise in blood pressure.
Iniston cough suppressant and DECONGESTANT can change the hypotensive effect of antihypertensive medicines.
It should not be taken with certain antidepressant medications (MAOIs) so if you are being treated with any of them consult your doctor or pharmacist before taking this medicine (see CONTRAINDICATIONS and PRECAUTIONS).
Depression or central nervous system excitation, drowsiness, sleep disturbances, hallucinations, skin rash with or without irritation, tachycardia, dry mouth, nose and throat may occur gastrointestinal discomfort and difficulty urinating.
The simultaneous use of alcohol during treatment may enhance the appearance of side effects. Do not drink alcoholic beverages during it.
OVERDOSE AND ITS TREATMENT
Symptoms and signs and overdose are: gastrointestinal discomfort, nausea, vomiting, drowsiness, lethargy, rapid eye movements, weakness, respiratory depression, dry skin and mucous membranes, tachycardia, hypertension, increased temperature, hyperactivity, irritability and seizures , difficulty urinating.
In the treatment for acute overdosage should be applied therapeutic measures necessary under these circumstances. Go to a medical center stating the product and the amount ingested.
Accidental ingestion of very high doses can result in children a state of torpor or alterations in gait. These effects disappear by inducing vomiting and gastric lavage.
In case of respiratory depression, naloxone and ventilatory support.
Convulsions, benzodiazepines administered intravenously or rectally, depending on age.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone +34 91 562 04 20